{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T05:23:04Z","timestamp":1791868984141,"version":"4.3.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2010,5,27]],"date-time":"2010-05-27T00:00:00Z","timestamp":1274918400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1007\/s00259-010-1490-5","type":"journal-article","created":{"date-parts":[[2010,5,26]],"date-time":"2010-05-26T10:00:48Z","timestamp":1274868048000},"page":"1824-1833","source":"Crossref","is-referenced-by-count":286,"title":["Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma"],"prefix":"10.1007","volume":"37","author":[{"given":"Sally F.","family":"Barrington","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendi","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward J.","family":"Somer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Franceschetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Bagni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Brun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hel\u00e9n","family":"Almquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Loft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liselotte","family":"H\u00f8jgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Federico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Gallamini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Radford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"O\u2019Doherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,5,27]]},"reference":[{"key":"1490_CR1","doi-asserted-by":"crossref","first-page":"21S","DOI":"10.2967\/jnumed.108.057190","volume":"50","author":"M Hutchings","year":"2009","unstructured":"Hutchings M, Barrington SF. PET\/CT for therapy response assessment in lymphoma. J Nucl Med 2009;50:21S\u201330S.","journal-title":"J Nucl Med"},{"key":"1490_CR2","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1200\/JCO.2007.11.6525","volume":"25","author":"A Gallamini","year":"2007","unstructured":"Gallamini A, Hutchings M, Rigacci L, Specht L, Merli F, Hansen M, et al. Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma: a report from a joint Italian-Danish study. J Clin Oncol 2007;25:3746\u201352.","journal-title":"J Clin Oncol"},{"key":"1490_CR3","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1093\/annonc\/mdi200","volume":"16","author":"M Hutchings","year":"2005","unstructured":"Hutchings M, Mikhaeel NG, Fields PA, Nunan T, Timothy AR. Prognostic value of interim FDG-PET after two or three cycles of chemotherapy in Hodgkin lymphoma. Ann Oncol 2005;16:1160\u20138.","journal-title":"Ann Oncol"},{"key":"1490_CR4","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1093\/annonc\/mdi272","volume":"16","author":"NG Mikhaeel","year":"2005","unstructured":"Mikhaeel NG, Hutchings M, Fields PA, O'Doherty MJ, Timothy AR. FDG-PET after two to three cycles of chemotherapy predicts progression-free and overall survival in high-grade non-Hodgkin lymphoma. Ann Oncol 2005;16:1514\u201323.","journal-title":"Ann Oncol"},{"key":"1490_CR5","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1182\/blood-2009-08-234351","volume":"115","author":"SJ Horning","year":"2010","unstructured":"Horning SJ, Juweid ME, Schoder H, Wiseman G, McMillan A, Swinnen LJ, et al. Interim positron emission tomography (PET) scans in diffuse large B-cell lymphoma: an independent expert nuclear medicine evaluation of the Eastern Cooperative Oncology Group E3404 study. Blood 2010;115:775\u20137.","journal-title":"Blood"},{"key":"1490_CR6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/001316446002000104","volume":"20","author":"J Cohen","year":"1960","unstructured":"Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas 1960;20:37\u201346.","journal-title":"Educ Psychol Meas"},{"key":"1490_CR7","first-page":"396","volume-title":"Some common problems in medical research. Practical statistics for medical research","author":"DG Altman","year":"1999","unstructured":"Altman DG. Some common problems in medical research. Practical statistics for medical research. London: Chapman and Hall\/CRC; 1999. p. 396\u2013439."},{"key":"1490_CR8","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1097\/MNM.0b013e3282eff2d5","volume":"27","author":"JM Zijlstra","year":"2007","unstructured":"Zijlstra JM, Comans EF, van Lingen A, Hoekstra OS, Gundy CM, Willem Coebergh J, et al. FDG PET in lymphoma: the need for standardization of interpretation. An observer variation study. Nucl Med Commun 2007;28:798\u2013803.","journal-title":"Nucl Med Commun"},{"key":"1490_CR9","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00259-009-1092-2","volume":"36","author":"A Chiti","year":"2009","unstructured":"Chiti A. Evaluation of response: is 18F-FDG PET the answer? Eur J Nucl Med Mol Imaging 2009;36:733\u20134.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1490_CR10","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s00259-008-0946-3","volume":"36","author":"MS Hofman","year":"2009","unstructured":"Hofman MS, Smeeton NC, Rankin SC, Nunan T, O'Doherty MJ, Hofman MS, et al. Observer variation in FDG PET-CT for staging of non-small-cell lung carcinoma. Eur J Nucl Med Mol Imaging 2009;36:194\u20139.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1490_CR11","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1182\/blood-2005-06-2252","volume":"107","author":"M Hutchings","year":"2006","unstructured":"Hutchings M, Loft A, Hansen M, Pedersen LM, Buhl T, Jurlander J, et al. FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma. Blood 2006;107:52\u20139.","journal-title":"Blood"},{"key":"1490_CR12","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/annonc\/mdn629","volume":"20","author":"HS Han","year":"2009","unstructured":"Han HS, Escalon MP, Hsiao B, Serafini A, Lossos IS. High incidence of false-positive PET scans in patients with aggressive non-Hodgkin's lymphoma treated with rituximab-containing regimens. Ann Oncol 2009;20:309\u201318.","journal-title":"Ann Oncol"},{"key":"1490_CR13","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/hon.782","volume":"24","author":"M Hutchings","year":"2006","unstructured":"Hutchings M, Loft A, Hansen M, Ralfkiaer E, Specht L, Hutchings M, et al. Different histopathological subtypes of Hodgkin lymphoma show significantly different levels of FDG uptake. Hematol Oncol 2006;24:146\u201350.","journal-title":"Hematol Oncol"},{"key":"1490_CR14","first-page":"475","volume":"91","author":"A Gallamini","year":"2006","unstructured":"Gallamini A, Rigacci L, Merli F, Nassi L, Bosi A, Capodanno I, et al. The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin's disease. Haematologica 2006;91:475\u201381.","journal-title":"Haematologica"},{"key":"1490_CR15","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1002\/cncr.22276","volume":"107","author":"L Kostakoglu","year":"2006","unstructured":"Kostakoglu L, Goldsmith SJ, Leonard JP, Christos P, Furman RR, Atasever T, et al. FDG-PET after 1 cycle of therapy predicts outcome in diffuse large cell lymphoma and classic Hodgkin disease. Cancer 2006;107:2678\u201387.","journal-title":"Cancer"},{"key":"1490_CR16","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s00277-006-0151-z","volume":"85","author":"S Querellou","year":"2006","unstructured":"Querellou S, Valette F, Bodet-Milin C, Oudoux A, Carlier T, Harousseau JL, et al. FDG-PET\/CT predicts outcome in patients with aggressive non-Hodgkin's lymphoma and Hodgkin's disease. Ann Hematol 2006;85:759\u201367.","journal-title":"Ann Hematol"},{"key":"1490_CR17","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1200\/JCO.2006.08.2305","volume":"25","author":"ME Juweid","year":"2007","unstructured":"Juweid ME, Stroobants S, Hoekstra OS, Mottaghy FM, Dietlein M, Guermazi A, et al.; Imaging Subcommittee of International Harmonization Project in Lymphoma. Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. J Clin Oncol 2007;25:571\u20138.","journal-title":"J Clin Oncol"},{"key":"1490_CR18","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1080\/10428190903040048","volume":"50","author":"M Meignan","year":"2009","unstructured":"Meignan M, Gallamini A, Haioun C. Report on the First International Workshop on Interim-PET-Scan in Lymphoma. Leuk Lymphoma 2009;50:1257\u201360.","journal-title":"Leuk Lymphoma"},{"key":"1490_CR19","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.2967\/jnumed.107.042093","volume":"48","author":"C Lin","year":"2007","unstructured":"Lin C, Itti E, Haioun C, Petegnief Y, Luciani A, Dupuis J, et al. Early 18F-FDG PET for prediction of prognosis in patients with diffuse large B-cell lymphoma: SUV-based assessment versus visual analysis. J Nucl Med 2007;48:1626\u201332.","journal-title":"J Nucl Med"},{"key":"1490_CR20","doi-asserted-by":"crossref","first-page":"527","DOI":"10.2967\/jnumed.108.057703","volume":"50","author":"E Itti","year":"2009","unstructured":"Itti E, Lin C, Dupuis J, Paone G, Capacchione D, Rahmouni A, et al. Prognostic value of interim 18F-FDG PET in patients with diffuse large B-cell lymphoma: SUV-based assessment at 4 cycles of chemotherapy. J Nucl Med 2009;50:527\u201333.","journal-title":"J Nucl Med"},{"key":"1490_CR21","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s00259-005-1784-1","volume":"32","author":"AK Berthelsen","year":"2005","unstructured":"Berthelsen AK, Holm S, Loft A, Klausen TL, Andersen F, Hojgaard L. PET\/CT with intravenous contrast can be used for PET attenuation correction in cancer patients. Eur J Nucl Med Mol Imaging 2005;32:1167\u201375.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1490_CR22","first-page":"1643","volume":"47","author":"B Rodriguez-Vigil","year":"2006","unstructured":"Rodriguez-Vigil B, Gomez-Leon N, Pinilla I, Hernandez-Maraver D, Coya J, Martin-Curto L, et al. PET\/CT in lymphoma: prospective study of enhanced full-dose PET\/CT versus unenhanced low-dose PET\/CT. J Nucl Med 2006;47:1643\u20138.","journal-title":"J Nucl Med"},{"key":"1490_CR23","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1093\/annonc\/mdn282","volume":"19","author":"RL Elstrom","year":"2008","unstructured":"Elstrom RL, Leonard JP, Coleman M, Brown RKJ. Combined PET and low-dose, noncontrast CT scanning obviates the need for additional diagnostic contrast-enhanced CT scans in patients undergoing staging or restaging for lymphoma. Ann Oncol 2008;19:1770\u20133.","journal-title":"Ann Oncol"},{"key":"1490_CR24","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1007\/s00259-003-1169-2","volume":"30","author":"SF Barrington","year":"2003","unstructured":"Barrington SF, O'Doherty MJ. Limitations of PET for imaging lymphoma. Eur J Nucl Med Mol Imaging 2003;30:S117\u201327.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1490_CR25","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.2967\/jnumed.107.048983","volume":"49","author":"M Karam","year":"2008","unstructured":"Karam M, Roberts-Klein S, Shet N, Chang J, Feustel P, Karam M, et al. Bilateral hilar foci on 18F-FDG PET scan in patients without lung cancer: variables associated with benign and malignant etiology. J Nucl Med 2008;49:1429\u201336.","journal-title":"J Nucl Med"},{"key":"1490_CR26","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.2967\/jnumed.109.064121","volume":"50","author":"MS Hofman","year":"2009","unstructured":"Hofman MS, Smeeton NC, Rankin SC, Nunan T, O'Doherty MJ. Observer variation in interpreting 18F-FDG PET\/CT findings for lymphoma staging. J Nucl Med 2009;50:1594\u20137.","journal-title":"J Nucl Med"},{"key":"1490_CR27","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1200\/JCO.1999.17.7.2153","volume":"17","author":"BD Fletcher","year":"1999","unstructured":"Fletcher BD, Glicksman AS, Gieser P. Interobserver variability in the detection of cervical-thoracic Hodgkin's disease by computed tomography. J Clin Oncol. 1999;17:2153.","journal-title":"J Clin Oncol"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-010-1490-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-010-1490-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-010-1490-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T12:05:06Z","timestamp":1558699506000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-010-1490-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,27]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["1490"],"URL":"https:\/\/doi.org\/10.1007\/s00259-010-1490-5","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,27]]}}}